1,640 results match your criteria: "Hospital Clinico Universitario Virgen de la Arrixaca[Affiliation]"
Front Immunol
December 2024
Immunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFAn Pediatr (Engl Ed)
December 2024
Comité de Salud Medioambiental, Global Alliance for Rewilding Child and Adolescent Health, Asociación Española de Pediatría, Madrid, Spain; Pediatric Environmental Health Speciality Unit (PEHSU), Hospital Clínico Universitario Virgen de la Arrixaca, Universidad de Murcia. Murcia, Spain. Electronic address:
Actas Dermosifiliogr
December 2024
Servicio de Oncología Médica, Hospital Clínico Universitario Virgen de la Arrixaca, Ciudad de Murcia, Spain; Instituto Murciano de Investigación Biosanitaria (IMIB), Spain.
Introduction: Clinical trials have validated the use of nivolumab and pembrolizumab as adjuvant therapies regarding relapse-free survival (RFS) in patients with resected stage III and IV melanoma. Evidence in real-world patients is currently limited.
Material And Method: The CADIM trial (Characterization of adjuvant immunotherapy in melanoma patients) recruited a total of 81 patients with resected stage III and IV melanoma on nivolumab or pembrolizumab as adjuvant therapy from February 2018 through December 2022.
Lab Anim
December 2024
Instituto Murciano de Investigación Biomédica-Pascual Parrilla, Murcia, Spain.
The purpose of this study is to provide a detailed account of our successful experience in establishing a functional zebrafish holding facility by repurposing materials from a previous installation. On the eve of the start-up of our new animal facility we were notified that a research centre was putting part of its zebrafish holding facility (29 racks, accessories, water treatment unit) up for sale. Although the originally planned room was designed for six double racks, but encouraged by the increasing use of the zebrafish model, we decided to seize the opportunity, purchase the equipment and utilize it to create a larger configuration and an independent quarantine to protect the main facility.
View Article and Find Full Text PDFRev Esp Anestesiol Reanim (Engl Ed)
December 2024
Departamento de Anestesiología y Reanimación, Hospital del Mar - Instituto de Investigación (IMIM), Barcelona, Spain.
Objective: To assess the perioperative management of haemostasis and transfusion practices in adult patients undergoing craniotomies.
Method: Online questionnaire addressed to Spanish anaesthesiologists and promoted by the Neurosciences and Haemostasis, Transfusion Medicine and Fluid Therapy Sections of SEDAR. The questionnaire was sent by email and social media, and was active between June and October 2022.
Front Endocrinol (Lausanne)
December 2024
Department of Pediatrics, Hospital Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.
Objective: Idiopathic central precocious puberty (CPP) precipitates epiphyseal fusion of growth plates in long bones, leading to reduced adult stature. Gonadotropin-releasing hormone analogues (GnRHa) are the treatment of choice for idiopathic CPP, but their benefit on height gain is unclear. We aimed to elucidate the effects of GnRHa treatment on adult height in girls with idiopathic CPP.
View Article and Find Full Text PDFMed Clin (Barc)
December 2024
Laboratorio Regional de Salud Pública, Consejería de Salud de la Región de Murcia, Murcia, Spain.
Introduction: Soils contaminated by heavy metals such as lead, cadmium, and arsenic represent a significant health risk. The Sierra Minera of Cartagena (Spain) is an area historically contaminated by mining activities. This study evaluates the exposure to heavy metals and proposes a clinical screening model for its management in primary care.
View Article and Find Full Text PDFJ Patient Rep Outcomes
December 2024
Sanofi, Barcelona, Spain.
Background: Alemtuzumab is a humanized monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Its efficacy and safety have been widely demonstrated in clinical trials, but experience from real-world cohorts is also needed to support its clinical use. Quality of life (QoL) outcomes are an important complement to the clinical benefits of treatment, offering a patient-centered perspective on how the drug contributes to general well-being.
View Article and Find Full Text PDFClin Nutr
January 2025
Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA)-BIONAND Platform, Málaga, Spain; Department of Medicine and Dermatology, Faculty of Medicine, University of Malaga, Malaga, Spain; Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Málaga, Spain. Electronic address:
Background And Aims: Parenteral nutrition (PN) composition could play a role in the management of systemic inflammatory response and intestinal barrier disruption. We aimed to evaluate changes in biomarkers of inflammation, oxidative status and intestinal permeability in patients with type 2 diabetes mellitus (T2DM) who received different PN lipid formulas.
Methods: This was a prospective study, including 94 patients with T2DM who received omega (n)-3 polyunsaturated fatty acids (PUFA)-enriched PN, a mixture of medium and long chain triglycerides (MCT/LCT) PN, or an olive oil-based PN.
Infect Dis (Lond)
December 2024
Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Spain.
Purpose: A analysis of data from a previously published clinical trial was conducted using the desirability of outcome ranking (DOOR) methodology with the aim provide additional information on the use of fosfomycin for the treatment of bacteraemic urinary tract infection (BUTI) caused by multi-drug-resistant (MDR) .
Methods: Three DOOR systems with five, six and seven categories, respectively were developed. Safety and efficacy were prioritised in all rankings, but step down to oral therapy and exposure to antibiotics with lower ecological impact were also considered in DOOR-6 and DOOR-7.
Nefrologia (Engl Ed)
December 2024
Servicio de Nefrología, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
An Pediatr (Engl Ed)
December 2024
Unidad de Endocrinología Pediátrica, AGC de la Infancia y Adolescencia, Hospital Universitario Central de Asturias, Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Facultad de Medicina y Ciencias de la Salud, Universidad de Oviedo, Oviedo, Spain.
Introduction: Patients with achondroplasia present, in addition to disproportionate short stature, multiple manifestations that require a comprehensive approach. The present consensus of experts in Spain responds to the need to establish clear guidelines for the management of achondroplasia with the introduction of a new treatment, vosoritide.
Material And Methods: A panel of six experts in achondroplasia participated in the development of the consensus.
Aten Primaria
December 2024
Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB)-Pascual Parrilla, Murcia, España; Departamento de Medicina Interna, Universidad de Murcia, Murcia, España.
Phys Med Biol
December 2024
Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, ctra. Madrid-Cartagena, 30120 El Palmar (Murcia), Spain.
. For calculating shielding in x-ray rooms, it is often assumed that the beams impinge perpendicularly on the protective barriers. This is not always true, but this premise simplifies the calculations and enhances protection by being a conservative calculation.
View Article and Find Full Text PDFJMIR Form Res
November 2024
Medical Department, Sandoz Farmacéutica, Madrid, Spain.
Background: Switching to biosimilars is an effective and safe practice in treating inflammatory diseases; however, a nocebo effect may arise as a result of the way in which the switch is communicated to a given patient.
Objective: We aimed to design a gaming-based digital educational tool (including a discussion algorithm) to support the training of health care professionals in efficiently communicating the switch to biosimilars, minimizing the generation of a nocebo effect and thus serving as an implementation strategy for the recommended switch.
Methods: The tool was developed based on interviews and focus group discussions with key stakeholders, both patients and health care professionals.
J Nutr Health Aging
November 2024
Department of Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Front Immunol
November 2024
Immunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Objective: To ascertain the changes of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) values in relapsing-remitting multiple sclerosis (RRMS) patients treated with ocrelizumab and their association with treatment response.
Methods: Multicenter prospective study including 115 RRMS patients initiating ocrelizumab treatment between February 2020 and March 2022 followed during a year. Serum samples were collected at baseline and every 3 months to measure sNfL and sGFAP levels using single-molecule array (SIMOA) technology.
Biomed J
November 2024
Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.
J Clin Med
November 2024
Reina Sofía Alzheimer Center, CIEN Foundation, ISCIII, 28031 Madrid, Spain.
J Alzheimers Dis
December 2024
Department of Food Science and Nutrition, Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain.
Background: Alzheimer's disease (AD) presents a significant challenge in healthcare, prompting exploration into non-pharmacological interventions to complement traditional treatments.
Objective: This systematic review explores the efficacy of lifestyle-based interventions in managing AD.
Methods: A comprehensive literature search was conducted in PubMed, Web of Science, and Scopus between 2018 and 2023, selecting randomized controlled trials examining factors such as exercise, diet, stress, and cognitive training in AD patients.
J Am Coll Cardiol
October 2024
Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas-CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address:
Background: Coagulase-negative staphylococci (CoNS) are an increasingly common cause of infective endocarditis (IE) and lack recent data from large studies.
Objectives: Our aim was to describe the epidemiology, clinical characteristics, and outcomes of staphylococcal IE in a contemporary nationwide cohort study, while comparing coagulase-negative staphylococcal IE (CoNSIE) to IE from Staphylococcus aureus (SAIE), and among IE caused by Staphylococcus epidermidis (SE), S. lugdunensis (SL), and other CoNS.
Front Bioeng Biotechnol
November 2024
Regeneración Oncología Molecular y TGF-β, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
During wound healing, the migration of keratinocytes is critical for wound closure. The application of amniotic membrane (AM) on wounds with challenging contexts (e.g.
View Article and Find Full Text PDFNeurocirugia (Astur : Engl Ed)
November 2024
Department of Neurosurgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
J Am Acad Dermatol
November 2024
Servicio de Dermatología, Hospital QuironSalud A Coruña, A Coruña, Spain.
Rev Esp Cardiol (Engl Ed)
November 2024
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides para la Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain.
Introduction And Objectives: To analyze the clinical impact of the inappropriate use of antithrombotic treatment in patients with high ischemic or hemorrhagic risk during the periprocedural/perisurgical period in Spain.
Methods: Prospective multicenter observational registry of patients receiving antiplatelet and/or anticoagulant therapy who required an intervention. The incidence of 30-day events was compared based on the peri-intervention management of antithrombotic treatment and the patients' risk classification (high vs.